These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30927630)

  • 1. Novel lipoprotein density profiling in laminitic, obese, and healthy horses.
    Coleman MC; Walzem RL; Kieffer AJ; Minamoto T; Suchodolski J; Cohen ND
    Domest Anim Endocrinol; 2019 Jul; 68():92-99. PubMed ID: 30927630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of endothelin in equine laminitis.
    Katwa LC; Johnson PJ; Ganjam VK; Kreeger JM; Messer NT
    Equine Vet J; 1999 May; 31(3):243-7. PubMed ID: 10402139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of p63, a regulator of epidermal stem cells, in the chronic laminitic equine hoof.
    Carter RA; Engiles JB; Megee SO; Senoo M; Galantino-Homer HL
    Equine Vet J; 2011 Sep; 43(5):543-51. PubMed ID: 21496086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of inflammatory markers in previously laminitic ponies.
    Wray H; Elliott J; Bailey SR; Harris PA; Menzies-Gow NJ
    Equine Vet J; 2013 Sep; 45(5):546-51. PubMed ID: 23418944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific dysregulation of cortisol metabolism in equine laminitis.
    Johnson PJ; Ganjam VK; Slight SH; Kreeger JM; Messer NT
    Equine Vet J; 2004 Jan; 36(1):41-5. PubMed ID: 14756370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma fructosamine concentrations in laminitic horses.
    Knowles EJ; Withers JM; Mair TS
    Equine Vet J; 2012 Mar; 44(2):226-9. PubMed ID: 21696439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cushing's syndromes, insulin resistance and endocrinopathic laminitis.
    Johnson PJ; Messer NT; Ganjam VK
    Equine Vet J; 2004 Apr; 36(3):194-8. PubMed ID: 15147123
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of a supplement containing chromium and magnesium on morphometric measurements, resting glucose, insulin concentrations and insulin sensitivity in laminitic obese horses.
    Chameroy KA; Frank N; Elliott SB; Boston RC
    Equine Vet J; 2011 Jul; 43(4):494-9. PubMed ID: 21496075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum markers of lamellar basement membrane degradation and lamellar histopathological changes in horses affected with laminitis.
    Johnson PJ; Kreeger JM; Keeler M; Ganjam VK; Messer NT
    Equine Vet J; 2000 Nov; 32(6):462-8. PubMed ID: 11093618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis.
    Guedes A; Galuppo L; Hood D; Hwang SH; Morisseau C; Hammock BD
    Equine Vet J; 2017 May; 49(3):345-351. PubMed ID: 27338788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrinological aspects of the pathophysiology of equine laminitis.
    Menzies-Gow N
    Equine Vet J; 2012 Nov; 44(6):735-7. PubMed ID: 23106624
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic perturbations in Welsh Ponies with insulin dysregulation, obesity, and laminitis.
    Jacob SI; Murray KJ; Rendahl AK; Geor RJ; Schultz NE; McCue ME
    J Vet Intern Med; 2018 May; 32(3):1215-1233. PubMed ID: 29572947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine serum lipids: serum lipoprotein profiles of Morgan and Thoroughbred horses.
    Robie SM; Smith SC; O'Connor JT
    Am J Vet Res; 1975 Dec; 36(12):1709-13. PubMed ID: 173210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the glycoxidative stress marker pentosidine with equine laminitis.
    Valle E; Storace D; Sanguineti R; Carter R; Odetti P; Geor R; Bergero D
    Vet J; 2013 Jun; 196(3):445-50. PubMed ID: 23206662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Animal welfare in prevention and therapy of laminitis].
    Winkelsett S; Vervuert I
    Dtsch Tierarztl Wochenschr; 2008 Mar; 115(3):106-13. PubMed ID: 18444467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of endoplasmic reticulum stress and the unfolded protein response in naturally-occurring endocrinopathic equine laminitis.
    Cassimeris L; Engiles JB; Galantino-Homer H
    BMC Vet Res; 2019 Jan; 15(1):24. PubMed ID: 30630474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic equine laminitis is characterised by loss of GLUT1, GLUT4 and ENaC positive laminar keratinocytes.
    Mobasheri A; Critchlow K; Clegg PD; Carter SD; Canessa CM
    Equine Vet J; 2004 Apr; 36(3):248-54. PubMed ID: 15147133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies.
    Carter RA; Treiber KH; Geor RJ; Douglass L; Harris PA
    Equine Vet J; 2009 Feb; 41(2):171-8. PubMed ID: 19418747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear magnetic resonance-based metabonomic study of early time point laminitis in an oligofructose-overload model.
    Keller MD; Pollitt CC; Marx UC
    Equine Vet J; 2011 Nov; 43(6):737-43. PubMed ID: 21496096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equine laminitis: a journey to the dark side of venous.
    Robertson TP; Bailey SR; Peroni JF
    Vet Immunol Immunopathol; 2009 Jun; 129(3-4):164-6. PubMed ID: 19110318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.